| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.09. | Fangzhou Inc.: Fangzhou's 'XingShi' LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care | 1 | GlobeNewswire (USA) | ||
| 25.09. | FANGZHOU JIANKE (06086): 2025 INTERIM REPORT | - | HKEx | ||
| 18.09. | Fangzhou Inc.: Fangzhou Named 'Outstanding Growth Story in Hong Kong Stocks' at China Capital Market Development Forum 2025 | 1 | GlobeNewswire (USA) | ||
| 18.09. | Fangzhou Inc.: Fangzhou Wins Gilead 'Award of Excellence' for AI-Driven Chronic Disease Management | 13 | GlobeNewswire (USA) | ||
| 15.09. | FANGZHOU JIANKE (06086): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES | - | HKEx | ||
| 14.09. | Fangzhou Inc.: Fangzhou Unveils "XingShi" LLM to Advance AI-Driven Chronic Disease Management | 2 | GlobeNewswire (USA) | ||
| 10.09. | Fangzhou Inc.: Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions | 340 | GlobeNewswire (Europe) | SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent... ► Artikel lesen | |
| FANGZHOU Aktie jetzt für 0€ handeln | |||||
| 03.09. | Fangzhou Inc.: Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research | 2 | GlobeNewswire (USA) | ||
| 27.08. | Fangzhou Inc.: Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand | 338 | PR Newswire | HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported... ► Artikel lesen | |
| 27.08. | FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 3 | HKEx | ||
| 15.08. | FANGZHOU JIANKE (06086): DATE OF BOARD MEETING | - | HKEx | ||
| 21.07. | Fangzhou and Novo Nordisk link on chronic disease management | 44 | Pharmaceutical Technology | ||
| 21.07. | Fangzhou And Novo Nordisk Collaborate To Combat Chronic Diseases | 45 | RTTNews | ||
| 18.07. | Novo Nordisk, Fangzhou Partner to Tackle Chronic Diseases | 58 | Mexico Business News | ||
| 18.07. | Fangzhou Inc.: Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management | 443 | PR Newswire | BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum... ► Artikel lesen | |
| 19.06. | FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 19, 2025 | 1 | HKEx | ||
| 18.06. | FANGZHOU JIANKE (06086): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
| 18.06. | FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 18.06. | FANGZHOU JIANKE (06086): APPOINTMENT OF MEMBER OF THE NOMINATION COMMITTEE | - | HKEx | ||
| 27.05. | FANGZHOU JIANKE (06086): INVITATION LETTER TO REGISTERED SHAREHOLDERS FOR ONLINE ATTENDANCE AT 2025 ANNUAL GENERAL MEETING | 1 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 33,500 | 0,00 % | Jefferies hebt Kursziel für BrightSpring Health wegen starker Fundamentaldaten auf 36 US-Dollar an | ||
| FRESENIUS | 48,970 | +1,43 % | ROUNDUP/Aktien Frankfurt Eröffnung: Dax sackt unter 24.000 Punkte | FRANKFURT (dpa-AFX) - Der Dax hat am Freitag kräftig nachgegeben. In den USA hatte am Vorabend die Bilanzqualität kleinerer Regionalbanken die Anleger an der Wall Street verschreckt, als zwei Häuser... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,490 | -1,44 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC vor Zahlen für das dritte Quartal auf "Underweight" mit einem Kursziel von 41,50 Euro belassen. Die Geschäftsbeschleunigung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,360 | +0,04 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 59 Euro belassen. Mit der Reifung des Gesundheitssystems... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,290 | -0,66 % | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | ||
| GERRESHEIMER | 27,940 | +0,87 % | KAUFCHANCE!? Gerresheimer Absturz! Renk Korrektur! Nakiki Aktie auf den Bitcoin-Spuren von Strategy und Metaplanet! | Die Nakiki SE elektrisiert mehr und mehr Aktieninvestoren und die Bitcoinwelt. Auf den Spuren von Strategy will man zum ersten deutschen Bitcoin Treasury Unternehmen im regulierten Markt werden. Rund... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 47,220 | -0,30 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 35,10 Euro belassen. Anchal Verma sieht in einer am Freitag vorliegenden... ► Artikel lesen | |
| PICARD MEDICAL | 13,270 | 0,00 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2025 Financial Results | Strong commercial momentum driven by higher product sales - Total revenue and $19.5 million IPO proceeds support expansion and innovation in artificial heart technology - TUSCON, Ariz., Sept. 15,... ► Artikel lesen | |
| OTTOBOCK | 69,20 | +3,21 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD® Medical | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD® Medical
24.10.2025 / 07:44... ► Artikel lesen | |
| HEARTFLOW | 39,910 | +1,54 % | Heartflow, Inc.: New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning | ||
| LIFESTANCE HEALTH GROUP | 5,140 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| KINDLY MD | 0,795 | 0,00 % | KindlyMD, Inc: KindlyMD Announces Strategic Partnership with Antalpha and Intent to Establish $250 Million Convertible Debt Facility | First Step in Broader Effort to Develop Innovative Financing Tools for the Bitcoin MarketCollaboration Launches Initial Treasury Financing Structure SALT LAKE CITY, UTAH / ACCESS Newswire / October... ► Artikel lesen | |
| PROGYNY | 19,500 | +1,72 % | Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause | Global employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health... ► Artikel lesen | |
| GOODRX | 3,860 | +2,39 % | GoodRx Stock Could Get a Major Trump Boost. Should You Buy It Here? | ||
| SANARA MEDTECH | 30,080 | -4,05 % | Sanara MedTech Inc. Announces Chief Executive Officer Transition | Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," the "Company... ► Artikel lesen |